Prefusion Stabilized Spike Protein
Lab Reagents
Human IgG antibody Laboratories manufactures the prefusion stabilized spike protein reagents distributed by Genprice. The Prefusion Stabilized Spike Protein reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Protein. Other Prefusion products are available in stock. Specificity: Prefusion Category: Stabilized Group: Spike Protein
Human Alpha Synuclein Oligomers (Dopamine HCL Stabilized) |
|||
| SPR-466B | Stressmarq | 0.1 mg | EUR 724.8 |
|
Description: Untagged recombinant human Alpha Synuclein Protein expressed in E. coli for WB, SDS-PAGE, In vivo assay, In vitro assay. The biological activity of this protein has not yet been tested. |
|||
Human Alpha Synuclein Oligomers (Dopamine HCL Stabilized) |
|||
| SPR-466C | Stressmarq | 2x0.1 mg | EUR 1112.4 |
|
Description: Untagged recombinant human Alpha Synuclein Protein expressed in E. coli for WB, SDS-PAGE, In vivo assay, In vitro assay. The biological activity of this protein has not yet been tested. |
|||
Human Alpha Synuclein Oligomers (Dopamine HCL Stabilized) |
|||
| SPR-466E | Stressmarq | 5x0.1 mg | EUR 2170.8 |
|
Description: Untagged recombinant human Alpha Synuclein Protein expressed in E. coli for WB, SDS-PAGE, In vivo assay, In vitro assay. The biological activity of this protein has not yet been tested. |
|||
Alkaline Phosphatase [CIAP] *Stabilized in aqueous solution* |
|||
| 11900 | AAT Bioquest | 5000 U | EUR 99 |
SARS Spike RBD Recombinant Protein |
|||
| 10-211 | ProSci | 0.1 mg | EUR 651.3 |
|
Description: The spike protein (S) of coronavirus (CoV) attaches the virus to its cellular receptor, angiotensinconverting enzyme 2 (ACE2). A defined receptor-binding domain (RBD) on S mediates this interaction.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
|||
MERS Spike S1 Recombinant protein |
|||
| 39-102 | ProSci | 0.1 mg | EUR 556.8 |
|
Description: Since April 2012, cases of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) have been identified in the following countries: Saudi Arabia, Qatar, Jordan, the United Arab Emirates, Oman, Kuwait, Yemen, Lebanon, Iran, Algeria, the United Kingdom, France, Italy, Greece, Germany, the Netherlands, Austria, Tunisia, Egypt, Malaysia, Turkey and the United States of America. Coronaviruses are the cause of the common cold, SARS (severe acute respiratory syndrome) and other severe illnesses with high mortality rates, all are classified into coronavirus family. MERS-CoV is a new type of SARS found in the coronavirus family causing severe pneumonia with sudden and serious respiratory illness with high mortality rates as well. Since January 27th 2015, the WHO has reported 956 human cases, including 351 deaths. More cases of the new coronavirus strain are expected. Like in other coronaviruses, large surface spike glycoprotein is a central structural protein of this virus; it is located above the virion surface to bind and enter into the target cell. Spike protein has 2 domains- S1 and S2. The S1 domain is responsible for cellular tropism and interaction with target cell, while the S2 domain is responsible for membrane fusion. The C-terminal of S1 domain contains a receptor binding domain, and is also a potential target for vaccine development and an antigen for diagnosis. |
|||
SARS-CoV spike protein Antibody |
|||
| abx023139-100ug | Abbexa | 100 ug | EUR 1028.4 |
SARS-CoV spike protein Antibody |
|||
| abx023143-100ug | Abbexa | 100 ug | EUR 1028.4 |
SARS Spike Peptide |
|||
| 3219P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (NT) SARS Spike peptide |
|||
SARS Spike Peptide |
|||
| 3525P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (CT) SARS Spike peptide |
|||
SARS Spike Antibody |
|||
| 24216-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
| 24217-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
| 24218-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
| 24219-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
| 24318-100ul | SAB | 100ul | EUR 468 |
SARS Spike Antibody |
|||
| 20-abx137184 | Abbexa |
|
|
SARS Spike Antibody |
|||
| 20-abx137200 | Abbexa |
|
|